Nevertheless, our functional assays demonstrate the importance of Gi/o-GPCR signaling in maintaining the stemness of CSCs for tumorigenesis and therapeutic resistance in HER2+ breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.